Leukodystrophy Metachromatic

This is a form of white matter dystrophy, a type of progressive degenerative disease of the nervous system. Leukodystrophy metachromatica could be described as a complex type of neurodegenerative disease that affects the tissues of the brain and spinal cord, is progressive and often leads to dementia and disability.

Scholz syndrome is a rare pathology caused by hereditary disorders of serotonin metabolism that underlie the development of neuronal degeneration and deafferentation. Various mutations of several genes responsible for the synthesis lead to the development of pathology

Metachromatic leukodystrophy is a disease characterized by degeneration and death of the white matter of the brain.

**Leukodystrophies** are a group of rare hereditary diseases manifested by destruction, dystrophy of the white matter of the spinal cord, clinically arising as severe disorders of motor skills, conductive functions or functions of maintaining vital processes in the form of mental disorders, less often combined syndromes. The term L. was proposed in 1953 by the Italian neurohigerontist J. Scholz. Under this name, various diseases from the group of progressive, later regressively progressive diseases of the human central nervous system are combined. Diseases are characterized by disturbances

Leukodystrophies are a group of hereditary diseases that lead to impaired development of nervous tissue. One of these diseases is metachromatic leukodystrophy (l. metachromatica).

This disease manifests itself in the form of decreased intelligence, speech impairment, motor coordination and other neurological symptoms. The cause of the disease is a mutation in the gene that is responsible for the synthesis of proteins necessary for the normal development of the nervous system.

Treatment for metachromatic leukodystrophy may include drug therapy, surgery, and other treatments. However, in most cases, treatment does not lead to complete recovery, and the disease remains for life.

In addition, there is a genetic test that can determine the risk of developing leukodystrophy in children whose parents have this disease. This allows you to start treatment in a timely manner and prevent the development of the disease.

Thus, leukodystrophy is a serious disease that requires timely treatment and prevention. If you suspect that you or someone you love has this condition, see your doctor for diagnosis and treatment.